Cargando…

Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation

[Image: see text] The development of more complex in vitro models for the assessment of novel drugs and chemicals is needed because of the limited biological relevance of animal models to humans as well as ethical considerations. Although some human-cell-based assays exist, they are usually 2D, cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrington, Helen, Cato, Paul, Salazar, Fabian, Wilkinson, Malcolm, Knox, Alan, Haycock, John W., Rose, Felicity, Aylott, Jon W., Ghaemmaghami, Amir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086737/
https://www.ncbi.nlm.nih.gov/pubmed/24628276
http://dx.doi.org/10.1021/mp5000295
_version_ 1782324845438042112
author Harrington, Helen
Cato, Paul
Salazar, Fabian
Wilkinson, Malcolm
Knox, Alan
Haycock, John W.
Rose, Felicity
Aylott, Jon W.
Ghaemmaghami, Amir M.
author_facet Harrington, Helen
Cato, Paul
Salazar, Fabian
Wilkinson, Malcolm
Knox, Alan
Haycock, John W.
Rose, Felicity
Aylott, Jon W.
Ghaemmaghami, Amir M.
author_sort Harrington, Helen
collection PubMed
description [Image: see text] The development of more complex in vitro models for the assessment of novel drugs and chemicals is needed because of the limited biological relevance of animal models to humans as well as ethical considerations. Although some human-cell-based assays exist, they are usually 2D, consist of single cell type, and have limited cellular and functional representation of the native tissue. In this study, we have used biomimetic porous electrospun scaffolds to develop an immunocompetent 3D model of the human respiratory tract comprised of three key cell types present in upper airway epithelium. The three cell types, namely, epithelial cells (providing a physical barrier), fibroblasts (extracellular matrix production), and dendritic cells (immune sensing), were initially grown on individual scaffolds and then assembled into the 3D multicell tissue model. The epithelial layer was cultured at the air–liquid interface for up to four weeks, leading to formation of a functional barrier as evidenced by an increase in transepithelial electrical resistance (TEER) and tight junction formation. The response of epithelial cells to allergen exposure was monitored by quantifying changes in TEER readings and by assessment of cellular tight junctions using immunostaining. It was found that epithelial cells cocultured with fibroblasts formed a functional epithelial barrier at a quicker rate than single cultures of epithelial cells and that the recovery from allergen exposure was also more rapid. Also, our data show that dendritic cells within this model remain viable and responsive to external stimulation as evidenced by their migration within the 3D construct in response to allergen challenge. This model provides an easy to assemble and physiologically relevant 3D model of human airway epithelium that can be used for studies aiming at better understanding lung biology, the cross-talk between immune cells, and airborne allergens and pathogens as well as drug delivery.
format Online
Article
Text
id pubmed-4086737
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-40867372014-07-09 Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation Harrington, Helen Cato, Paul Salazar, Fabian Wilkinson, Malcolm Knox, Alan Haycock, John W. Rose, Felicity Aylott, Jon W. Ghaemmaghami, Amir M. Mol Pharm [Image: see text] The development of more complex in vitro models for the assessment of novel drugs and chemicals is needed because of the limited biological relevance of animal models to humans as well as ethical considerations. Although some human-cell-based assays exist, they are usually 2D, consist of single cell type, and have limited cellular and functional representation of the native tissue. In this study, we have used biomimetic porous electrospun scaffolds to develop an immunocompetent 3D model of the human respiratory tract comprised of three key cell types present in upper airway epithelium. The three cell types, namely, epithelial cells (providing a physical barrier), fibroblasts (extracellular matrix production), and dendritic cells (immune sensing), were initially grown on individual scaffolds and then assembled into the 3D multicell tissue model. The epithelial layer was cultured at the air–liquid interface for up to four weeks, leading to formation of a functional barrier as evidenced by an increase in transepithelial electrical resistance (TEER) and tight junction formation. The response of epithelial cells to allergen exposure was monitored by quantifying changes in TEER readings and by assessment of cellular tight junctions using immunostaining. It was found that epithelial cells cocultured with fibroblasts formed a functional epithelial barrier at a quicker rate than single cultures of epithelial cells and that the recovery from allergen exposure was also more rapid. Also, our data show that dendritic cells within this model remain viable and responsive to external stimulation as evidenced by their migration within the 3D construct in response to allergen challenge. This model provides an easy to assemble and physiologically relevant 3D model of human airway epithelium that can be used for studies aiming at better understanding lung biology, the cross-talk between immune cells, and airborne allergens and pathogens as well as drug delivery. American Chemical Society 2014-03-14 2014-07-07 /pmc/articles/PMC4086737/ /pubmed/24628276 http://dx.doi.org/10.1021/mp5000295 Text en Copyright © 2014 American Chemical Society Terms of Use CC-BY (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html)
spellingShingle Harrington, Helen
Cato, Paul
Salazar, Fabian
Wilkinson, Malcolm
Knox, Alan
Haycock, John W.
Rose, Felicity
Aylott, Jon W.
Ghaemmaghami, Amir M.
Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation
title Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation
title_full Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation
title_fullStr Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation
title_full_unstemmed Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation
title_short Immunocompetent 3D Model of Human Upper Airway for Disease Modeling and In Vitro Drug Evaluation
title_sort immunocompetent 3d model of human upper airway for disease modeling and in vitro drug evaluation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086737/
https://www.ncbi.nlm.nih.gov/pubmed/24628276
http://dx.doi.org/10.1021/mp5000295
work_keys_str_mv AT harringtonhelen immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT catopaul immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT salazarfabian immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT wilkinsonmalcolm immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT knoxalan immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT haycockjohnw immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT rosefelicity immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT aylottjonw immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation
AT ghaemmaghamiamirm immunocompetent3dmodelofhumanupperairwayfordiseasemodelingandinvitrodrugevaluation